A 16-year neonatal/pediatric extracorporeal membrane oxygenation transport experience

Pediatrics

Volumn 109, Issue 2 I, 2002, Pages 189-193

  Bernard Jr , J Wilson ^a   Heiman, Howard S ^b   Butler, Thomas J ^a   Negaard, Kathryn A ^b   DiGeronimo, Robert ^a,c  

^a San Antonio Military Pediatric Center   (United States)

^b Children's Hospital   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Child; Congenital heart defects; Extracorporeal membrane oxygenation; Infant; Newborn; Respiratory insufficiency; Transportation of patients

Indexed keywords

AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; MALE; MECONIUM ASPIRATION; MORTALITY; NEWBORN; NEWBORN MORTALITY; PATIENT REFERRAL; PATIENT TRANSPORT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SURVIVAL; TREATMENT PLANNING;

EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART DEFECTS, CONGENITAL; HOSPITALS, MILITARY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MECONIUM ASPIRATION SYNDROME; MOBILE HEALTH UNITS; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY INSUFFICIENCY; SURVIVAL RATE; TEXAS; TRANSPORTATION OF PATIENTS;

EID: 0036161711     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.2.189     Document Type: Article

References (11)

1. ELSO Registry Report, International Summary
2. Extracorporeal membrane oxygenation as a means of stabilizing and transporting high risk neonates
3. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the ELSO registry
4. Interhospital transport of neonatal patients on extracorporeal membrane oxygenation: Mobile ECMO
5. Hidden mortality rate associated with extracorporeal membrane oxygenation
6. Prospective, randomized comparison of high frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation
7. Multicenter study of surfactant (beractant) in treatment of term infants with severe respiratory failure
8. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory, failure
9. ECMO in evolution: The impact of changing patient demographics and alternative therapies on ECMO
10. Use of inhaled nitric oxide
11. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn